Ultragenyx Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
27.03.25
/
50%
€36.00
Target price
27.03.26
€108.68
Performance (%)
-53.33%
End price
28.03.26
€16.80
Summary
This prediction ended on 28.03.26 with a price of €16.80. Massive losses of -53.33% were the result for the BUY prediction by JPMorgan_Chase___Co_. JPMorgan_Chase___Co_ has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.699% | -1.699% | -1.111% |
| iShares Core DAX® | 0.625% | 4.952% | 8.658% |
| iShares Nasdaq 100 | 1.160% | -1.160% | 26.817% |
| iShares Nikkei 225® | 2.356% | -1.354% | 48.195% |
| iShares S&P 500 | 0.631% | 1.380% | 22.985% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at JPMorgan Chase & Co. from $104.00 to $117.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€19.10
12.03.26
12.03.26
€64.16
12.03.27
12.03.27
22.15%
12.08.26
12.08.26
Stopped prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€44.00
21.11.24
21.11.24
€96.83
21.11.25
21.11.25
-34.09%
22.11.25
22.11.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.60
27.02.24
27.02.24
€81.12
27.02.25
27.02.25
-17.74%
28.02.25
28.02.25